Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood. 2002 Jul 15; 100(2):627-34.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Cannabinoids
Cell Survival
Dose-Response Relationship, Drug
Dronabinol
Drug Evaluation, Preclinical
Humans
Leukemia, Lymphoid
Ligands
Mice
Mice, Inbred C57BL
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Receptors, Cannabinoid
Receptors, Drug
Survival Rate
Treatment Outcome
Tumor Cells, Cultured
authors with profiles
Mitzi Nagarkatti